Louisiana State Employees Retirement System reduced its position in shares of Solventum Co. (NYSE:SOLV – Free Report) by 5.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 7,400 shares of the company’s stock after selling 400 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Solventum were worth $489,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Modus Advisors LLC bought a new position in shares of Solventum during the 4th quarter valued at approximately $25,000. Copeland Capital Management LLC bought a new position in shares of Solventum during the 3rd quarter valued at approximately $26,000. Stonebridge Financial Group LLC bought a new position in shares of Solventum during the 4th quarter valued at approximately $26,000. Crews Bank & Trust bought a new position in shares of Solventum during the 4th quarter valued at approximately $32,000. Finally, True Wealth Design LLC boosted its position in shares of Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after acquiring an additional 471 shares during the last quarter.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on SOLV. Piper Sandler raised their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Morgan Stanley raised their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Finally, Mizuho began coverage on Solventum in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target for the company. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $68.29.
Solventum Stock Up 0.0 %
NYSE:SOLV opened at $74.27 on Wednesday. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05. The stock has a fifty day simple moving average of $70.82 and a 200-day simple moving average of $68.76. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.
Solventum Company Profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
See Also
- Five stocks we like better than Solventum
- The Significance of Brokerage Rankings in Stock Selection
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- ESG Stocks, What Investors Should Know
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Stock Market Upgrades: What Are They?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLV – Free Report).
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.